Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Market sluggish

<< Previous

Bullboard Posts

Next >>

Comment by Vimon66on Jul 28, 2017 10:33pm

99 Views

Post# 26524416

RE:Market sluggish

There margins are so low that there is no substantial value creation even on the long run. With time if you get stuck onboard you'll come to hope for one thing only and that is a buyout offer. Let's pray that the board doesn't get too at ease cause if the past is any indications of what the future holds, we surely shouldn't expect riches any time soon. Good luck to you anyway!

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale